Azathioprine Dosing in Adults
The recommended starting dose of azathioprine for adults is 1 mg/kg/day, which can be gradually increased to 1-2 mg/kg/day as tolerated, with appropriate blood count monitoring. 1
Initial Dosing Strategy
The most recent and authoritative guidelines from the British Society of Gastroenterology (2025) provide clear dosing recommendations:
- Start at 1 mg/kg/day as the standard initial dose 1
- As steroid doses are reduced during treatment, azathioprine can be gradually increased from 1 to 2 mg/kg/day with appropriate blood count monitoring 1
- In children, higher doses of 2.0-2.5 mg/kg/day are typically used 1
The 2025 EASL guidelines for autoimmune hepatitis similarly recommend starting at 50 mg/day and gradually increasing to 1-2 mg/kg/day according to body weight 2. The FDA label indicates a broader range of 1-3 mg/kg/day for maintenance therapy in transplant patients, but lower doses (1-2 mg/kg/day) are standard for inflammatory conditions 3.
Critical Pre-Treatment Considerations
Before starting azathioprine, TPMT (thiopurine methyltransferase) enzyme activity should be measured if readily available to exclude homozygous TPMT deficiency 1. This is a strong recommendation with moderate evidence:
- Homozygous TPMT deficiency (very low/absent activity): Azathioprine is contraindicated due to high risk of life-threatening myelosuppression. Use mycophenolate mofetil instead 1, 4, 3
- Heterozygous TPMT deficiency (intermediate activity): The 2025 BSG guidelines note insufficient evidence for routine dose reduction at initiation 1. However, the FDA label recommends dosage reduction in heterozygous patients 3, and dermatology guidelines suggest 1.0-1.5 mg/kg/day for intermediate TPMT activity 5
- Normal TPMT activity: Standard dosing of 1-2 mg/kg/day can be used 1, 5
Timing of Initiation
Azathioprine introduction is often delayed 2 weeks after starting steroids, though this is not mandatory 1. A multicenter study found that delaying azathioprine beyond 2 weeks showed no difference in remission rates, adverse effects, or discontinuation compared to early initiation 1, 6. There is no compelling reason to delay beyond 2 weeks, especially since azathioprine metabolites take up to 8 weeks to reach steady state 1.
Dose Escalation and Maintenance
The evidence supports a gradual approach:
- Begin at 1 mg/kg/day
- As prednisolone is tapered (typically over 1-3 months to 5-10 mg/day), azathioprine can be increased gradually to 2 mg/kg/day 1
- This escalation should be guided by blood count monitoring and clinical response
- The 2015 EASL guidelines provide a specific example: for a 60 kg patient, start at 50 mg/day at week 3, increase to 100 mg/day by week 5 7
Context-Specific Dosing
For inflammatory bowel disease: The 2025 AGA guidelines recommend 2-2.5 mg/kg/day for azathioprine monotherapy in patients with normal drug metabolism 8. Research suggests that 2 mg/kg/day is more effective than 1 mg/kg/day for Crohn's disease in Asian populations, with higher remission rates and lower recurrence without increased adverse events 9.
For dermatological conditions: Guidelines recommend 1-3 mg/kg/day, adjusted according to response, with TPMT-based dosing of 2.0-3.0 mg/kg/day for normal TPMT activity 4, 5.
For transplantation: Initial doses are higher (3-5 mg/kg/day), then reduced to maintenance levels of 1-3 mg/kg/day 3.
Important Caveats
- Monitoring is essential regardless of TPMT status, as TPMT testing only identifies a proportion of patients at risk for hematological toxicity 5
- Azathioprine should be promptly reduced or stopped if significant bone marrow depression occurs 1
- The most common adverse effect is myelosuppression, occurring in approximately 7% of patients 10
- Discontinuation rates in the first year are approximately 15%, primarily due to intolerance (nausea/vomiting) 6
- Avoid in decompensated cirrhosis, current/recent malignancy, and pregnancy 1
- Contraindicated with concurrent allopurinol due to risk of severe myelosuppression 4